Evidence map›Paper›PMID 37533428›Full record

ArticleGynecologic oncology reports2023

High-grade endometrial stromal sarcoma with

Yuko Takahashi, Yoshinao Kikuchi, Junji Mukaiyama, Shiori Watabe, Toshihiro Haga, Yuko Miyagawa, Asako Yamamoto, Yoshikane Yamauchi, Haruko Hiraike, Kenbun Sone and 3 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Gynecologic oncology reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Yuko TakahashiDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Japan.
Yoshinao KikuchiDepartment of Pathology, Teikyo University School of Medicine, Japan.
Junji MukaiyamaDepartment of Pathology, Teikyo University School of Medicine, Japan.
Shiori WatabeDepartment of Pathology, Teikyo University School of Medicine, Japan.
Toshihiro HagaDepartment of Pathology, Teikyo University School of Medicine, Japan.
Yuko MiyagawaDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Japan.
Asako YamamotoDepartment of Radiology, Teikyo University School of Medicine, Japan.
Yoshikane YamauchiDepartment of Surgery, Teikyo University School of Medicine, Japan.
Haruko HiraikeDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Japan.
Kenbun SoneDepartment of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Japan.
Yuko SasajimaDepartment of Pathology, Teikyo University School of Medicine, Japan.
Akihiko YoshidaDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital, Japan.
Kazunori NagasakaDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Japan.
Teikyo University · JPNational Cancer Center · USNational Cancer Center Hospital East · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

•Endometrial stromal sarcoma is the second most common type of uterine sarcoma.•Endometrial stromal sarcoma has undergone modifications since its proposal.•This case highlights the importance of accurately diagnosing endometrial stromal sarcoma.•Asymptomatic uterine fibroids may not be treated with therapeutic intervention or prompt regular check-ups.

Identifiers

PMID37533428
PMCPMC10391924
OpenAlexW4384831002

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.